Somatostatin analogs: does pharmacology impact antitumor efficacy?Mounira Chalabi, Corinne Bousquet, Camille Duluc et al.|Trends in Endocrinology and Metabolism|2014Cited by 97
Current Scientific Rationale for the Use of Somatostatin Analogs and mTOR Inhibitors in Neuroendocrine Tumor TherapyCorinne Bousquet, Stéphane Pyronnet, Charline Lasfargues et al.|The Journal of Clinical Endocrinology & Metabolism|2011Cited by 87
Targeting cancer-associated fibroblasts through inhibition of protein synthesis to abrogate resistance to chemotherapies in pancreatic cancerCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|Pancreatology|2014Cited by 1
Abstract B60: Critical role of hemidesmosome breakdown for human pancreatic cancer cell migration and invasion.Séverine Laval, Corinne Bousquet, Mounira Chalabi et al.|Tumor Biology|2012Cited by 0
Somatostatin receptor haploinsufficiency accelerates KrasG12D-initiated pancreatic carcinogenesis by promoting inflammationMounira Chalabi, Corinne Bousquet, Stéphanie Cassant‐Sourdy et al.|Pancreatology|2013Cited by 0